Paclikaas is a sterile injectable formulation of Paclitaxel, a widely used chemotherapy drug effective against various cancers. It acts by stabilizing microtubules, preventing cancer cell division and inducing apoptosis.

Available Strengths:

• 30 mg

• 100 mg

• 260 mg

Therapeutic Indications:

• Breast Cancer

• Ovarian Cancer

• Non-Small Cell Lung Cancer (NSCLC)

• Kaposi’s Sarcoma

• Other solid tumors

Mechanism of Action:
Paclitaxel binds to microtubules, promoting their assembly and inhibiting disassembly, which disrupts the mitotic process and halts cell proliferation.

Key Features:

• Manufactured under GMP-compliant conditions

• High purity and consistent potency

• Supplied as a sterile solution for intravenous infusion

• Requires premedication to reduce hypersensitivity reactions

• Widely recognized standard of care in oncology

Packaging:

• Sterile vials containing 30 mg, 100 mg, or 260 mg of Paclitaxel for reconstitution and administration

Storage:
Store 25°C -30°C. Protect from moisture and light. Keep out of reach of children.

Note: Administer under strict medical supervision with appropriate premedication.